News

39 Verrill Attorneys Named 2019 Super Lawyers and Rising Stars

December 11, 2019 Press Releases

Verrill Attorney Karen Frink Wolf Again Named One of New England’s Top 100 Attorneys and Top 50 Women Attorneys

(December 11, 2019) – The 2019 edition of New England Super Lawyers and Rising Stars© has recognized a total of 39 Verrill attorneys for excellence in their individual areas of practice.

Only the top 5% of attorneys in each New England state are included in the Super Lawyers guide, and only the top 2.5% in each state are selected as Rising Stars, which identifies the best attorneys 40 years and under, or who have been practicing for 10 years or fewer. The selection process includes independent research, peer nominations and peer evaluations.

Below is the listing, by resident office, of attorneys from Verrill who have been honored by New England Super Lawyers and Rising Stars©. Congratulations to Karen Frink Wolf who was included in both the Top 100 New England Super Lawyers and the Top 50 Women.

Westport, Conn.

  • Andrew B. Nevas (Business Litigation)
  • Frank J. Silvestri, Jr. (Business Litigation)
  • Calvin K. Woo (Business Litigation)

Portland, Maine

  • Eric D. Altholz (Employee Benefits)
  • Scott D. Anderson (Environmental)
  • Robert C. Brooks (Employment & Labor)
  • Juliet T. Browne (Environmental)
  • Roger A. Clement, Jr. (Bankruptcy: Business)
  • James I. Cohen (Utilities)
  • Douglas P. Currier (Employment & Labor)
  • Harold J. Friedman (Personal Injury Products: Defense)
  • Martha C. Gaythwaite (Personal Injury Products: Defense)
  • John P. Giffune (Construction Litigation)
  • Kurt E. Klebe (Estate & Probate)
  • Suzanne E. Meeker (Employee Benefits)
  • Richard G. Moon (Employment & Labor)
  • A. Robert Ruesch (Construction Litigation)
  • Timothy R. Shannon (Business Litigation)
  • Karen Frink Wolf (Personal Injury Medical Malpractice: Defense) *Top 100, Top 50 Women

Rising Stars (Portland)

  • Tawny L. Alvarez (Employment & Labor)
  • Seth S. Coburn (Intellectual Property Litigation)
  • Benjamin E. Ford (Business Litigation)
  • Nathaniel R. Hull (Bankruptcy: Business)
  • Christopher S. Lockman (Employee Benefits)
  • Marie J. Mueller (General Litigation)
  • Misti D. Munster (Employee Benefits)
  • Stephen B. Segal (Civil Litigation: Defense)
  • Mathew J. Todaro (Environmental)

Boston, Mass.

  • Thomas O. Bean (Business Litigation)
  • Gene Dahmen (Family Law)
  • Michael L. Fay (Estate Planning & Probate)
  • Keith E. Glidden (Business Litigation)
  • Regina M. Hurley (Family Law)
  • Paul W. Shaw (Health Care)

Rising Stars (Boston)

  • Kristin S. Doeberl (Family Law)
  • Sarah R. Grandfield (Estate Planning & Probate)
  • Eugene H. Ho (Mergers & Acquisitions)
  • Kyle T. MacDonald (Family Law)
  • Andrew P. Rusczek (Health Care)
  • Marylana Saadeh Helou (Health Care)

Firm Highlights

Publication/Podcast

Updated FDA COVID-19 Guidance for Conduct of Clinical Trials

On March 27, 2020, the U.S. Food & Drug Administration (“FDA”) updated its prior guidance on the “ Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic ,” with an appendix adding a...

Matter

European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...

Publication/Podcast

Due to COVID-19, Federal Agencies Relax Requirements Regarding the Provision of Telehealth Services

In the past few days, in an effort to help keep Medicare beneficiaries healthy during the COVID-19 pandemic, key federal agencies within the U.S. Department of Health and Human Services (“HHS”) and the U.S...

News

Michael K. Fee to Lead Verrill’s Health Care and Life Sciences Defense Practice

(January 22, 2020) – Verrill is pleased to welcome Michael K. Fee to the firm’s Boston office as a Partner in its nationally recognized Health Care & Life Sciences Group and as the leader...

Matter

Common Rule

Guided multiple clients through the implementation of the revised HHS regulations (the "Common Rule"), including reviewing and revising policies and procedures, and assisting with institutional approaches to implementation.

Publication/Podcast

Responsible Research During the COVID-19 Pandemic

Publication/Podcast

COVID-19: FDA Clinical Trial Guidance

On March 18, 2020, the U.S. Food & Drug Administration (“FDA”) published guidance for clinical trial sponsors, investigators, and institutional review boards (“IRBs”) on conducting clinical trials in the midst of the COVID-19 pandemic...

Publication/Podcast

COVID-19 Expanded Access Template

We are aware that many companies and health care providers are working to expedite the transfer of investigational drugs that may be helpful in treating patients suffering from COVID-19. Although these expanded access arrangements...

Matter

Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...

Matter

Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.